MarkWide Research - Global Market Intelligence Platform
Home›Industries›Healthcare›Endoscopy

Endoscopy Market Reports

Endoscopy encompasses minimally invasive diagnostic and therapeutic procedures that visualize internal organs through flexible or rigid scopes inserted via natural openings or small incisions. Gastroenterology, pulmonology, urology, and gynecology applications dominate procedural volumes, while single-use devices and AI-assisted polyp detection are gaining traction among hospital systems and ambulatory surgery centers. Reimbursement shifts toward outpatient settings and tightening infection-control standards are redrawing competitive lines between device manufacturers and service operators.

103 Reports Found
Global Endoscopic Clips Market

The Global Endoscopic Clips Market valued at $920.5 Million in 2026 is projected to expand to $1,809.64 Million by 2035, advancing at a 7.80% CAGR over the analysis window. Ambulatory surgery centers now drive faster clip adoption than traditional hospitals. FDA and MDR frameworks tighten biocompatibility testing for implantable clip materials. Demand concentrates in Germany, Japan, and the United States.

View More
Single Use Bronchoscopes Market

The Single Use Bronchoscopes Market is sized at $312.4 Million in 2026 and is projected to expand to $1,263.85 Million by 2035, advancing at a 16.80% CAGR over the analysis window. Intensive care units across hospital systems are expanding adoption of single-use devices to eliminate cross-contamination between immunocompromised patients. FDA reprocessing guidelines and updated EU MDR sterility requirements are tilting procurement toward factory-sterilized disposable platforms. Demand concentrates most acutely in the United States, where hospital-acquired infection liability costs drive premium willingness for guaranteed sterile bronchoscopy.

View More
US Colonic Stents Market

The US Colonic Stents Market valued at $78.4 Million in 2026 is projected to expand to $134.72 Million by 2035, advancing at a 6.20% CAGR over the analysis window. Hospital-based gastroenterology departments are expanding stent placement volumes as minimally invasive alternatives to surgical resection gain preference. FDA's evolving guidance on medical device biocompatibility testing is elevating compliance costs for manufacturers. Demand concentrates in the Southeast, where aging demographics and expanding hospital networks in Florida and Georgia drive procedure growth.

View More

Get Expert Help

Can't find what you need? Our analysts will help you locate or build the right report for your requirements.

Contact Our Team →